bosentan anhydrous has been researched along with Anasarca in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bräuer, R; Gajda, M; Glück, L; Imhof, AK; Schaible, HG; Schulz, S | 1 |
| Coghlan, G; Foster, W | 1 |
| Filep, JG; Földes-Filep, E; Fournier, A | 1 |
| D'Orléans-Juste, P; Piovezan, AP; Rae, GA; Tonussi, CR | 1 |
4 other study(ies) available for bosentan anhydrous and Anasarca
| Article | Year |
|---|---|
Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Arthralgia; Arthritis, Experimental; Bosentan; Disease Models, Animal; Edema; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Female; Ganglia, Spinal; Mice; Mice, Inbred C57BL; Nociception; Phenylpropionates; Pyridazines; Secondary Prevention; Sulfonamides | 2011 |
Images in cardiovascular medicine. Medical treatment of varicose veins.
Topics: Antihypertensive Agents; Bosentan; Edema; Female; Humans; Sulfonamides; Treatment Outcome; Varicose Veins | 2005 |
Effects of the ETA/ETB receptor antagonist, bosentan on endothelin-1-induced myocardial ischaemia and oedema in the rat.
Topics: Animals; Blood Vessels; Bosentan; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Electrocardiography; Endothelins; Heart; Male; Myocardial Ischemia; Permeability; Rats; Rats, Wistar; Sulfonamides | 1995 |
Endothelins potentiate formalin-induced nociception and paw edema in mice.
Topics: Animals; Bosentan; Dose-Response Relationship, Drug; Drug Synergism; Edema; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-2; Formaldehyde; Male; Mice; Nociceptors; Pain Measurement; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides; Viper Venoms | 1997 |